Innovent Expands Internationally With Indonesia Deal

Licensing Agreement Reached With Etana For Byvasda Bevacizumab Biosimilar

Innovent Biologics has broadened its international reach by striking a licensing deal with PT Etana Biotechnologies in Indonesia for its Byvasda bevacizumab biosimilar.

Indonesia Map Magnifying Glass
Innovent has licensed bevacizumab to Etana in Indonesia • Source: Shutterstock

China’s Innovent Biologics has expanded its international marketing network by agreeing a licensing deal for its Byvasda (bevacizumab) biosimilar version of Avastin in Indonesia with local firm PT Etana Biotechnologies Indonesia.

In exchange for Etana gaining development and commercialization rights in Indonesia to Byvasda, Innovent will receive development and commercialization milestone...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.